Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-28

Clinical Trial Update: Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating desmopressin (DDAVP) to improve platelet activity in intracerebral hemorrhage; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DDAVP (desmopressin acetate)

Snippet

Sponsor: Northwestern University | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: COMPLETED | Results posted: 2014-08-28